Sonovia has raised US$10 million through an IPO
Sonovia Ltd. has raised funds to refinance and develop the company.
Sonovia’s ground-breaking technology SonoFinishing™ helps to keep away bacteria, viruses and fungi of all kinds. It has been perfected over the years and proven in labs around the world. The company offers a commercial solution that eliminates the need for chemical binders, polymers, plastics and other harmful chemicals, and dramatically reduces the consumption of water in the process, yielding reusable and practical products and services at competitive prices.
Oaklins’ team in Israel advised the company and acted as the leader of the distributors’ consortium.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreBackspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn more